Defining the cellular precursors to human breast cancer
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Human breast cancers are broadly classified based on their gene-expression profiles into luminal- and basal-type tumors. These two major tumor subtypes express markers corresponding to the major differentiation states of epithelial cells in the breast: luminal (EpCAM + ) and basal/myoepithelial (CD10 + ). However, there are also rare types of breast cancers, such as metaplastic carcinomas, where tumor cells exhibit features of alternate cell types that no longer resemble breast epithelium. Until now, it has been difficult to identify the cell type(s) in the human breast that gives rise to these various forms of breast cancer. Here we report that transformation of EpCAM + epithelial cells results in the formation of common forms of human breast cancer, including estrogen receptor-positive and estrogen receptor-negative tumors with luminal and basal-like characteristics, respectively, whereas transformation of CD10 + cells results in the development of rare metaplastic tumors reminiscent of the claudin-low subtype. We also demonstrate the existence of CD10 + breast cells with metaplastic traits that can give rise to skin and epidermal tissues. Furthermore, we show that the development of metaplastic breast cancer is attributable, in part, to the transformation of these metaplastic breast epithelial cells. These findings identify normal cellular precursors to human breast cancers and reveal the existence of a population of cells with epidermal progenitor activity within adult human breast tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Prat, A., Parker, J. S., Karginova, O., Fan, C., Livasy, C., Herschkowitz, J. I., He, X., & Perou, C. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2635 · Cited by 2,167 · cited 3×
“Consistent with GSEA, when tumor differentiation was analyzed with the recently described Genomic Differentiation Predictor (4), tumors derived from EpCAM cells were more differentiated compared with CD10 and unsorted-derived tumors (P = 0.”
InfluentialSelf-citationkConFab, Lim, E., Vaillant, F., Wu, D., Forrest, N. C., Pal, B., Hart, A. H., Asselin-Labat, M.-L., Gyorki, D. E., Ward, T., et al. (2009) · Nature Medicine · doi:10.1038/nm.2000 · Cited by 1,492 · cited 7×
“that EpCAMCD49f cells enrich for stem/progenitor competency (11, 17, 18).”
BackgroundResultInfluentialBasal-Like Breast Cancer: A Critical Review
Rakha, E. A., Reis-Filho, J. S., & Ellis, I. O. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1748 · Cited by 1,164 · cited 1×
“ER tumors also encompass rare cancers, such as medullary, adenoid cystic, and metaplastic carcinomas, where the tumor cells not only lack ER-responsive and luminal genes but also exhibit features of alternate cell types not found in normal breast epithelium (2, 3).”
BackgroundPhenotypic evaluation of the basal-like subtype of invasive breast carcinoma
Livasy, C. A., Karaca, G., Nanda, R., Tretiakova, M. S., Olopade, O. I., Moore, D. T., & Perou, C. M. (2006) · Modern Pathology · doi:10.1038/modpathol.3800528 · Cited by 1,063 · cited 1×
“This finding is in agreement with the previously speculated but untested hypothesis that human basal-like breast cancers may arise from luminal progenitor cells and the observation that most basal-like tumors lack CD10 expression (5, 11, 12, 24).”
ResultSelf-citationHuman breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878 · cited 2×
“Consistent with previous reports (22), transformed vHMECs formed tumors that exhibited mixed epidermal and metaplastic features including squamous, spindle-cell, medullary, and giant cell differentiation (Fig.”
MethodResultHennessy, B. T., Gonzalez-Angulo, A.-M., Stemke-Hale, K., Gilcrease, M. Z., Krishnamurthy, S., Lee, J.-S., Fridlyand, J., Sahin, A., Agarwal, R., Joy, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3441 · Cited by 874 · cited 1×
“3 E), which are associated with metaplastic, mesenchymal, and mammary stem cell-like characteristics (4, 19).”
BackgroundSelf-citationReconstruction of functionally normal and malignant human breast tissues in mice
Kuperwasser, C., Chavarria, T., Wu, M., Magrane, G., Gray, J. W., Carey, L., Richardson, A., & Weinberg, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401064101 · Cited by 804 · cited 2×
“In this study, we sought to examine the relationship between luminal and basal/ME cells and breast cancer subtypes through use of the recently described human-in-mouse (HIM) model (13, 14).”
Self-citationImmunologic classification of leukemia and lymphoma.
Foon, K. A., & Todd, R. F. (1986) · PubMed · doi:10.1182/blood.v68.1.1.1 · Cited by 736
Breast cancer: origins and evolution
Polyak, K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33295 · Cited by 697 · cited 2×
“Discussion The enumeration of the cellular and functional activities of various cell types within human and mouse mammary tissues has been an area of intense investigation for understanding the cellular origins of breast cancers (10).”
BackgroundTriple-negative breast cancer—current status and future directions
Gluz, O., Liedtke, C., Gottschalk, N., Pusztai, L., Nitz, U., & Harbeck, N. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp492 · Cited by 687 · cited 1×
“ER tumors also encompass rare cancers, such as medullary, adenoid cystic, and metaplastic carcinomas, where the tumor cells not only lack ER-responsive and luminal genes but also exhibit features of alternate cell types not found in normal breast epithelium (2, 3).”
BackgroundWeigelt, B., Horlings, H., Kreike, B., Hayes, M., Hauptmann, M., Wessels, L., de Jong, D., Van de Vijver, M., Veer, L. V., & Peterse, J. (2008) · The Journal of Pathology · doi:10.1002/path.2407 · Cited by 562
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation
Gupta, P. B., Kuperwasser, C., Brunet, J.-P., Ramaswamy, S., Kuo, W.-L., Gray, J. W., Naber, S. P., & Weinberg, R. A. (2005) · Nature Genetics · doi:10.1038/ng1634 · Cited by 439 · cited 1×
“Moreover, in the case of solid tumors, the intrinsic differentiation programs of cellular precursors were shown to contribute to the heterogeneity and behavior of tumor cells (8, 9).”
BackgroundSelf-citationEvidence for a stem cell hierarchy in the adult human breast
Villadsen, R., Fridriksdottir, A. J., Rønnov-Jessen, L., Gudjonsson, T., Rank, F., LaBarge, M. A., Bissell, M. J., & Petersen, O. W. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611114 · Cited by 418 · cited 3×
“Although breast stem/progenitor cells have been localized to cells within both main and terminal ducts (16), the precise identity of human mammary stem cells is an area of contentious debate and remains ill defined.”
BackgroundResultGenetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate
Proia, T. A., Keller, P. J., Gupta, P. B., Klebba, I., Jones, A. D., Sedic, M., Gilmore, H., Tung, N., Naber, S. P., Schnitt, S., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.007 · Cited by 393
Self-citationGudjonsson, T., Villadsen, R., Nielsen, H. L., Rønnov-Jessen, L., Bissell, M. J., & Petersen, O. W. (2002) · Genes & Development · doi:10.1101/gad.952602 · Cited by 390 · cited 2×
“EpCAMMUC1 cells or EpCAMCD49f cells were first reported to enrich for cells with bipotent potential in human tissues (15, 16).”
BackgroundResultCharacterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue
Stingl, J., Eaves, C. J., Zandieh, I., & Emerman, J. T. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010615124301 · Cited by 367 · cited 2×
“that EpCAMCD49f cells enrich for stem/progenitor competency (11, 17, 18).”
BackgroundResultEirew, P., Stingl, J., Raouf, A., Turashvili, G., Aparicio, S., Emerman, J. T., & Eaves, C. J. (2008) · Nature Medicine · doi:10.1038/nm.1791 · Cited by 339 · cited 2×
“that EpCAMCD49f cells enrich for stem/progenitor competency (11, 17, 18).”
BackgroundResultTransformation of Different Human Breast Epithelial Cell Types Leads to Distinct Tumor Phenotypes
Ince, T. A., Richardson, A. L., Bell, G. W., Saitoh, M., Godar, S., Karnoub, A. E., Iglehart, J. D., & Weinberg, R. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.06.013 · Cited by 309 · cited 1×
“Moreover, in the case of solid tumors, the intrinsic differentiation programs of cellular precursors were shown to contribute to the heterogeneity and behavior of tumor cells (8, 9).”
BackgroundDistinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
Hollestelle, A., Nagel, J. H. A., Smid, M., Lam, S., Elstrodt, F., Wasielewski, M., Ng, S. S., French, P. J., Peeters, J. K., Rozendaal, M. J., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0460-8 · Cited by 301 · cited 1×
“Because carcinoma cells from luminal ER and basal-like ER breast cancers are reported to contain distinguishing and even mutually exclusive sets of mutated or misregulated genes (25), the genetic and epigenetic alterations sustained during early stages of transformation could alter differentiation commitment programs…”
BackgroundKeller, P. J., Lin, A. F., Arendt, L. M., Klebba, I., Jones, A. D., Rudnick, J. A., DiMeo, T. A., Gilmore, H., Jefferson, D. M., Graham, R. A., et al. (2010) · Breast Cancer Research · doi:10.1186/bcr2755 · Cited by 209 · cited 4×
“Consistent with our previous reports (5, 12), flow cytometry analysis of reduction mammoplasty tissues for EpCAM and CD49f expression indicated that four populations of epithelial cells could be identified: EpCAMCD49f, EpCAMCD49f, EpCAMCD49f, and EpCAMCD49f cells.”
BackgroundResultInfluentialSelf-citationMolecular Subtypes in Breast Cancer Evaluation and Management: Divide and Conquer
Peppercorn, J., Perou, C. M., & Carey, L. A. (2008) · Cancer Investigation · doi:10.1080/07357900701784238 · Cited by 197 · cited 1×
“They are broadly categorized into two types, ER and ER tumors, but can be further subdivided molecularly and histologically into subclasses with different prognostic outcomes and therapeutic sensitivities (1).”
BackgroundSelf-citationCooperation of signalling pathways in embryonic mammary gland development
Robinson, G. W. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2227 · Cited by 194
Huschtscha, L. I., Noble, J. R., Neumann, A. A., Moy, E. L., Barry, P. A., Melki, J. R., Clark, S. J., & Reddel, R. R. (1998) · PubMed · Cited by 187
Role of mesenchymal-epithelial interactions in mammary gland development
Cunha, G. R., & Hom, Y. K. (1996) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/bf02096300 · Cited by 170
Interaction with the mammary microenvironment redirects spermatogenic cell fate in vivo
Boulanger, C. A., Mack, D. L., Booth, B. W., & Smith, G. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611637104 · Cited by 157
Garbe, J. C., Bhattacharya, S., Merchant, B., Bassett, E., Swisshelm, K., Feiler, H. S., Wyrobek, A. J., & Stampfer, M. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0270 · Cited by 157 · cited 14×
“In contrast, basal/ME lineage CD10+ cells preferentially grew as adherent colonies, suggesting that CD10+ cells represent the greatest contribution of cells that expand in monolayer culture from unsorted HMECs under serum-free conditions (P = 0.004; Fig.”
BackgroundResultInfluentialReconstruction of human mammary tissues in a mouse model
Proia, D. A., & Kuperwasser, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.31 · Cited by 155 · cited 2×
“In this study, we sought to examine the relationship between luminal and basal/ME cells and breast cancer subtypes through use of the recently described human-in-mouse (HIM) model (13, 14).”
MethodSelf-citationThe mammary microenvironment alters the differentiation repertoire of neural stem cells
Booth, B. W., Mack, D. L., Androutsellis-Theotokis, A., McKay, R. D. G., Boulanger, C. A., & Smith, G. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803214105 · Cited by 133
Taylor, R. A., Wang, H., Wilkinson, S. E., Richards, M. G., Britt, K. L., Vaillant, F., Lindeman, G. J., Visvader, J. E., Cunha, G. R., John, J. C. S., et al. (2009) · Stem Cells · doi:10.1002/stem.244 · Cited by 36
Cited by
Clinical implications of the intrinsic molecular subtypes of breast cancer
Prat, A., Pineda, E., Adamo, B., Galván, P., Fernández, A., Gaba, L., Díez, M., Viladot, M., Arance, A., & Muñoz, M. (2015) · The Breast · doi:10.1016/j.breast.2015.07.008 · Cited by 1,319
Self-citationLiu, S., Cong, Y., Wang, D., Sun, Y., Deng, L., Liu, Y., Martin-Trevino, R., Shang, L., McDermott, S. P., Landis, M. D., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.11.009 · Cited by 1,053
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
Gupta, P. B., Pastushenko, I., Skibinski, A., Blanpain, C., & Kuperwasser, C. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.11.011 · Cited by 598
Self-citationMolecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
Prat, A., Adamo, B., Cheang, M. C. U., Anders, C. K., Carey, L. A., & Perou, C. M. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0397 · Cited by 568
Self-citationMammary stem cells and the differentiation hierarchy: current status and perspectives
Visvader, J. E., & Stingl, J. (2014) · Genes & Development · doi:10.1101/gad.242511.114 · Cited by 562
Metadata
- Authors
- Keller, P. J., Arendt, L. M., Skibinski, A., Logvinenko, T., Klebba, I., Dong, S., Smith, A. E., Prat, A., Perou, C. M., Gilmore, H., Schnitt, S., Naber, S. P., Garlick, J. A., & Kuperwasser, C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2011-09-21
- Volume
- 109
- Issue
- 8
- Pages
- 2772-2777
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2041263494
- Cited by
- 233
- References
- 29
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.